Evidence map›Paper›PMID 28332498›Full record

ArticleNature communications2017

A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.

Gernot Walko, Samuel Woodhouse, Angela Oliveira Pisco, Emanuel Rognoni, Kifayathullah Liakath-Ali, Beate M Lichtenberger, Ajay Mishra, Stephanie B Telerman, Priyalakshmi Viswanathan, Meike Logtenberg and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Stairways to Advanced Therapies for Epidermolysis Bullosa.Cold Spring Harbor perspectives in biology · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Gernot WalkoCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Samuel WoodhouseCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Angela Oliveira PiscoCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Emanuel RognoniCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Kifayathullah Liakath-AliCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Beate M LichtenbergerCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Ajay MishraCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Stephanie B TelermanCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Priyalakshmi ViswanathanCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Meike LogtenbergCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Lisa M RenzCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Giacomo DonatiCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
Sven R QuistClinic for Dermatology and Venerology, Otto-von-Guericke-University, Leipziger Straße 44, Magdeburg D-39120, Germany.
Fiona M WattCentre for Stem Cells and Regenerative Medicine, Faculty of Life Sciences &Medicine, King's College London, 28th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
King's College London · GBGuy's Hospital · GBOtto-von-Guericke University Magdeburg · DE

Funding

Medical Research Council G1100073Wellcome Trust
6 · The paper itself

Abstract

Individual human epidermal cells differ in their self-renewal ability. To uncover the molecular basis for this heterogeneity, we performed genome-wide pooled RNA interference screens and identified genes conferring a clonal growth advantage on normal and neoplastic (cutaneous squamous cell carcinoma, cSCC) human epidermal cells. The Hippo effector YAP was amongst the top positive growth regulators in both screens. By integrating the Hippo network interactome with our data sets, we identify WW-binding protein 2 (WBP2) as an important co-factor of YAP that enhances YAP/TEAD-mediated gene transcription. YAP and WPB2 are upregulated in actively proliferating cells of mouse and human epidermis and cSCC, and downregulated during terminal differentiation. WBP2 deletion in mouse skin results in reduced proliferation in neonatal and wounded adult epidermis. In reconstituted epidermis YAP/WBP2 activity is controlled by intercellular adhesion rather than canonical Hippo signalling. We propose that defective intercellular adhesion contributes to uncontrolled cSCC growth by preventing inhibition of YAP/WBP2.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell Line, TumorCell ProliferationCells, CulturedEpidermal CellsFemaleGene Expression RegulationHumansMice, Inbred C57BLMice, Inbred CBAMice, KnockoutNuclear ProteinsStem CellsTrans-ActivatorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsNuclear ProteinsTrans-ActivatorsTranscription FactorsWBP2 protein, humanYY1AP1 protein, human

Identifiers

PMID28332498
PMCPMC5376649
OpenAlexW2599215083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.